Intensified thromboprophylaxis in COVID-19 critically ill patients: is it enough?

We read with great interest the review article by Skevaki et al.1, who analyzed laboratory characteristics of COVID-19 patients. They show that SARS-CoV-2 infection causes systemic disease, involving multiple organs and systems, including hyperactivation of the immune system and the clotting system. Indeed, initial reports of venous thrombotic events (VTE) in critically ill patients with SARS-CoV-2 have yielded prevalences of more than 40% 2 –4, prompting the empirical use of intensified thromboprophylaxis regimens.

Source: Journal of Infection - February 4, 2021 Category: Infectious Diseases Authors: Etienne de Montmollin, Doroth ée Faille, Valérie Andrieu, Nadine Ajzenberg, Jean-François Timsit Source Type: research